Speaker illustration

Professor Agata Magdalena Bielecka-Dabrowa

Medical University of Lodz, Lodz (Poland)

Member of:

European Society of Cardiology

Agata Bielecka-Dabrowa MD, PhD, FESC is a Professor and Head of Heart Failure Unit in Department of Cardiology and Congenital Diseases of Adults in the Polish Mother’s Memorial Hospital Research Institute in Lodz, Poland. She is also Head of Labolatory of Cardiac Diagnostics at Medical University of Lodz. Prof. Agata Bielecka-Dabrowa graduated in medicine from the Medical University of Lodz, Poland in 2005 and obtained her PhD from the same University in 2009. In 2012 she became a specialist in the field of cardiology. In 2016 she received the title of Assistant Professor et Medical University of Lodz and in 2018 the title of Associate Professor et Polish Mother’s Memorial Hospital Research Institute in Lodz. From 2014-2018 she was an independent consultant in cardiology in Military Medical Academy University Hospital – Central Veterans Hospital. Prof. Agata Bielecka-Dabrowa is involved into several fields of professional activity including: clinical cardiology, clinical rese

The breast cancer chemotherapy influence negatively exercise tolerance assessed in CPET three months after treatment

Event: Heart Failure 2024

Topic: Cardio-Oncology

Session: Cardiovascular disease in special populations - cardio-oncology 2

Thumbnail

Predictors of echocardiographic global longitudinal strain decrease after breast cancer treatment

Event: Heart Failure 2024

Topic: Cardio-Oncology

Session: Cardiovascular disease in special populations - cardio-oncology 2

Thumbnail

The effect of the gender on the risk of long-covid and cardiovascular complications in healthy patients without comorbidities- data from the polish long-COVID cardiovascular (PoLoCOV-CVD) study

Event: ESC Congress 2023

Topic: Cardiovascular Disease in Women

Session: Cardiovascular risk in women

Thumbnail

Factors influencing systemic coronary risk estimation 2 (SCORE 2)

Event: ESC Preventive Cardiology 2023

Topic: Cardiovascular Risk Assessment, Other

Session: Moderated ePoster 2

Thumbnail

Diagnostic usefulness of spiroergometry and risk factors of long -COVID in patients with normal left ventricular ejection fraction

Event: ESC Congress 2022

Topic: Spiroergometry

Session: Spiroergometry

Thumbnail

The outcomes of Fontan operation in patients with hypoplastic left heart syndrome (HLHS) versus other forms of univentricular heart

Event: ESC Congress 2022

Topic: Adult Congenital Heart Disease (ACHD)

Session: Markers of severity and tools to handle the Fontan circulation

Thumbnail

Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin aldosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Heart failure pharmacotherapy - Sacubitril/valsartan

Thumbnail

Obesity and body mass componentss influence exercise tolerance and the course of hypertension in perimenopausal women

Event: Heart Failure 2022

Topic: Hypertension, Other

Session: Heart Failure ePosters - focus on Comorbidities and special population

Thumbnail

Hydration status, BMI and troponin as factors of an impaired exercise tolerance in women over 40 with arterial hypertension

Event: ESC Congress 2021 - The Digital Experience

Topic: Prevention

Session: Chronic heart failure e-posters

Thumbnail

Patient after correction of Taussig-Bing anomaly with severe neoaortic regurgitation and after sudden cardiac arrest

Event: EuroEcho 2019

Topic: Echocardiography, Other

Session: Echocardiography, Other

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb